UBS AM’s X4 Pharmaceuticals XFOR Stock Holding History
Bought
Maintained
Sold
Other funds holding XFOR
SVCM
KCM
UBS AM's XFOR Position: Q3 2026 in Review
UBS AM opened a new position in X4 Pharmaceuticals (XFOR) in Q3 2026: 389 shares worth $1.13K. The stake represents ﹤0.01% of the portfolio and ranks #4111 among its holdings.
73 funds tracked by Wall St. Rank hold XFOR as of Q3 2026.
- UBS AM held 389 shares of X4 Pharmaceuticals worth $1.13K as of Q3 2026.
- X4 Pharmaceuticals was a new UBS AM position in Q3 2026.
- X4 Pharmaceuticals made up ﹤0.01% of UBS AM's portfolio in Q3 2026, its #4111 holding.
- 73 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q3 2026.
Based on UBS AM's 13F filing for Q3 2026, filed 16 Nov 2026.